Intrinsic Value

The intrinsic value of Qingdao Baheal Medical Inc (301015) under the Base Case is 25.52 CNY per share. Compared with the current market price of 23.91 CNY, the stock appears Undervalued by 6% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥25.52
Undervaluation 6%
Intrinsic Value
Price ¥23.91
Q

Qingdao Baheal Medical Inc is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor Qingdao Baheal Medical Inc
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥20.42
Get notified when the price drops into your buy zone
Intrinsic Value ¥25.52
Current Price ¥23.91
Margin of Safety 20% ¥20.42
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Qingdao Baheal Medical Inc

Fundamental Analysis

What Qingdao Baheal Medical Does

Health Care

Qingdao Baheal Medical is a healthcare distribution and marketing company. It does not mainly make drugs itself; instead, it helps medical and health products reach the market. Its business is built around selling medicines, medical devices, and other health-related products through hospital, pharmacy, distributor, and online channels.

Headquarters
China CN
Employees
2 396
IPO date
Jun 30, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Qingdao Baheal Medical Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Qingdao Baheal Medical Inc stock?

The intrinsic value for Qingdao Baheal Medical Inc (301015) under the Base Case is 25.52 CNY.

Is Qingdao Baheal Medical Inc stock undervalued or overvalued?

Compared with the current market price of 23.91 CNY, the stock appears Undervalued by 6% .

Back to Top